Review
Nature Reviews Cancer 8, 193-204 (March 2008) | doi:10.1038/nrc2342
DNA repair pathways as targets for cancer therapy
Thomas Helleday1,2, Eva Petermann1, Cecilia Lundin1, Ben Hodgson1 & Ricky A. Sharma1 About the authors
Abstract
DNA repair pathways can enable tumour cells to survive DNA damage that is induced by chemotherapeutic treatments; therefore, inhibitors of specific DNA repair pathways might prove efficacious when used in combination with DNA-damaging chemotherapeutic drugs. In addition, alterations in DNA repair pathways that arise during tumour development can make some cancer cells reliant on a reduced set of DNA repair pathways for survival. There is evidence that drugs that inhibit one of these pathways in such tumours could prove useful as single-agent therapies, with the potential advantage that this approach could be selective for tumour cells and have fewer side effects.
- View At a Glance
Author affiliations
- Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, off Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK.
- Department of Genetics Microbiology and Toxicology, Stockholm University, Svante Arrhenius väg 16, S-106 91 Stockholm, Sweden.
Correspondence to: Thomas Helleday1,2 Email: thomas.helleday@rob.ox.ac.uk
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Engineering Oncolytic Measles Virus to Circumvent the Intracellular Innate Immune ResponseMolecular Therapy Original Article
Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes?CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy?in SCID-hu Mouse?Derived T CellsMolecular Therapy Original Article
See all 3 matches for Research